Annual Total Long Term Liabilities
$13.11 M
-$1.67 M-11.28%
December 31, 2023
Summary
- As of February 26, 2025, FDMT annual total long term liabilities is $13.11 million, with the most recent change of -$1.67 million (-11.28%) on December 31, 2023.
- During the last 3 years, FDMT annual total long term liabilities has fallen by -$2.09 million (-13.74%).
- FDMT annual total long term liabilities is now -88.91% below its all-time high of $118.25 million, reached on December 31, 2019.
Performance
FDMT Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$21.61 M
+$9.24 M+74.68%
September 30, 2024
Summary
- As of February 26, 2025, FDMT quarterly total long term liabilities is $21.61 million, with the most recent change of +$9.24 million (+74.68%) on September 30, 2024.
- Over the past year, FDMT quarterly long term liabilities has increased by +$8.10 million (+59.92%).
- FDMT quarterly long term liabilities is now -81.72% below its all-time high of $118.25 million, reached on December 31, 2019.
Performance
FDMT Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
FDMT Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -11.3% | +59.9% |
3 y3 years | -13.7% | +59.9% |
5 y5 years | -88.8% | +59.9% |
FDMT Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -27.3% | at low | at high | +74.7% |
5 y | 5-year | -88.9% | at low | -81.7% | +389.3% |
alltime | all time | -88.9% | at low | -81.7% | +389.3% |
4D Molecular Therapeutics Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $21.61 M(+74.7%) |
Jun 2024 | - | $12.37 M(-4.2%) |
Mar 2024 | - | $12.92 M(-1.5%) |
Dec 2023 | $13.11 M(-11.3%) | $13.11 M(-3.0%) |
Sep 2023 | - | $13.52 M(-0.7%) |
Jun 2023 | - | $13.61 M(-3.7%) |
Mar 2023 | - | $14.14 M(-4.3%) |
Dec 2022 | $14.78 M | $14.78 M(-2.5%) |
Sep 2022 | - | $15.16 M(-5.8%) |
Jun 2022 | - | $16.09 M(-4.1%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $16.78 M(-7.0%) |
Dec 2021 | $18.04 M(+18.7%) | $18.04 M(+253.0%) |
Sep 2021 | - | $5.11 M(+15.7%) |
Jun 2021 | - | $4.42 M(-67.9%) |
Mar 2021 | - | $13.77 M(-9.4%) |
Dec 2020 | $15.20 M(-87.1%) | $15.20 M(+10.5%) |
Sep 2020 | - | $13.76 M(-88.4%) |
Dec 2019 | $118.25 M(+1.5%) | $118.25 M(+3.5%) |
Jun 2019 | - | $114.20 M(-2.0%) |
Dec 2018 | $116.50 M(+184.1%) | $116.50 M |
Dec 2017 | $41.00 M | - |
FAQ
- What is 4D Molecular Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics annual total long term liabilities year-on-year change?
- What is 4D Molecular Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics quarterly long term liabilities year-on-year change?
What is 4D Molecular Therapeutics annual total long term liabilities?
The current annual total long term liabilities of FDMT is $13.11 M
What is the all time high annual total long term liabilities for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high annual total long term liabilities is $118.25 M
What is 4D Molecular Therapeutics annual total long term liabilities year-on-year change?
Over the past year, FDMT annual total long term liabilities has changed by -$1.67 M (-11.28%)
What is 4D Molecular Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of FDMT is $21.61 M
What is the all time high quarterly long term liabilities for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high quarterly total long term liabilities is $118.25 M
What is 4D Molecular Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, FDMT quarterly total long term liabilities has changed by +$8.10 M (+59.92%)